ZIOPHARM ONCOLOGY INC (62) | Human Resources (23)
Browse by Subcategory
Recent Contracts
-
Separation Agreement, dated March 28, 2022, by and between the Registrant and Dr. Raffaele Baffa
(Filed With SEC on March 30, 2022)
-
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Raffaele Baffa
(Filed With SEC on March 30, 2022)
-
Consulting Agreement by and between the Company and Dr. Laurence Cooper, entered into on April 5, 2021
(Filed With SEC on April 9, 2021)
-
Form of Retention Bonus Agreement
(Filed With SEC on March 1, 2021)
-
Employment Agreement, dated September 30, 2020, by and between the Registrant and Raffaele Baffa
(Filed With SEC on March 30, 2022)
-
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Eleanor de Groot
(Filed With SEC on March 30, 2022)
-
Employment Agreement, dated April 23, 2019, by and between the Registrant and Eleanor de Groot
(Filed With SEC on March 30, 2022)
-
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Jill Buck
(Filed With SEC on March 30, 2022)
-
Employment Agreement, dated April 23, 2019, by and between the Registrant and Jill Buck
(Filed With SEC on March 30, 2022)
-
Employment Agreement by and between ZIOPHARM Oncology, Inc. and Kevin S. Boyle, Sr., dated August 24, 2021
(Filed With SEC on August 30, 2021)
-
Separation Agreement by and between the Company and Dr. Laurence Cooper, dated April 5, 2021
(Filed With SEC on April 9, 2021)
-
Employment Agreement by and between Ziopharm Oncology, Inc. and Heidi Hagen, dated February 25, 2021
(Filed With SEC on March 2, 2021)
-
Amendment to the Employment Agreement by and between the Registrant and Sath Shukla, dated as of November 23, 2020
(Filed With SEC on March 1, 2021)
-
Amendment to the Employment Agreement by and between the Registrant and Robert Hadfield, dated as of November 23, 2020
(Filed With SEC on March 1, 2021)
-
Form of Stock Option Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Form of Restricted Stock Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Consulting Agreement by and between Ziopharm Oncology Inc. and Danforth Advisors LLC, effective as of January 21, 2021
(Filed With SEC on February 23, 2021)
-
Ziopharm Oncology, Inc. 2020 Equity Incentive Plan
(Filed With SEC on July 1, 2020)
-
Separation Agreement and Release by and between the Company and Dr. David Mauney, effective May 26, 2020
(Filed With SEC on May 29, 2020)
-
Consulting Agreement by and between the Company and Dr. David Mauney, dated May 26, 2020
(Filed With SEC on May 29, 2020)
-
Employment Agreement by and between Ziopharm Oncology, Inc. and Sath Shukla
(Filed With SEC on July 24, 2019)
-
Employment Agreement, dated as of April 23, 2019, by and between the Company and Robert Hadfield
(Filed With SEC on April 29, 2019)
-
Employment Agreement, dated as of April 23, 2019, by and between the Company and David Mauney, M.D
(Filed With SEC on April 29, 2019)